Award
National Institute on Drug Abuse 5F31DA060673-03
Role of sleep disruption in cognitive impairment associated with methamphetamine use
Recipient
University of Mississippi Med CTR, Jackson, MS
Award Amount
$50,114.00
Ceiling
$50,114.00
Awarded
April 02, 2026
Identifier
5F31DA060673-03
A research project funded by the National Institute on Drug Abuse to study how methamphetamine-induced sleep disruption causes cognitive deficits, using rhesus monkeys and testing sleep aid interventions.
Description
This project aims to understand the role of sleep disruption in cognitive impairment related to methamphetamine use, with potential therapeutic implications using sleep aids like suvorexant. It involves studies on rhesus monkeys to evaluate the impact of methamphetamine-induced sleep disruption on cognition and tests interventions such as suvorexant.